Abstract
How can a vaccine be effective against an organism that in nature is poorly immunogenic? Children within hyperendemic areas are repeatedly infected with Plasmodium falciparum malaria over many years before the incidence of parasitemia, splenomegaly, and clinical disease decreases. This immunity, once acquired, may wane in the absence of repeated exposure to malaria. The theoretical problems of a malaria vaccine are further complicated by antigenic differences that exist between the different geographic strains of P. falciparum. James et al. (1932) observed that a patient who was resistant to challenge with the Indian strain of P. falciparum was susceptible to the Sardinian strain. On the other hand, gamma globulin from immune, adult West Africians suppressed falciparum parasitemia in East African children (McGregor et al. 1963). In addition, antigenic differences do not appear to exist between sporozoites of falciparum strains isolated from Asia and Panama; individuals who were immunized by irradiated sporozoites from one area of the world resisted challenge by sporozoites from other areas (Clyde et al. 1973).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Bibliography
Bass, C.C. & Johns, F.M. 1912. The cultivation of malarial plasmodia (Plasmodium vivax and Plasmodium falciparum) in vitro. J. Exp. Med. 16: 567–579.
Bray, R.S. 1958. The susceptibility of Liberians to the Madagascar strain of Plasmodium vivax. J. Parasitol. 44: 371–373.
Brown, K.N., Brown, I.N. & Hills, L. 1970. Immunity to malaria. I. Protection against Plasmodium knowlesi shown by monkeys sensitized with drug-suppressed infections or by dead parasites in Freund’s adjuvant. Exp. Parasitol 28: 304–317.
Clyde, D.F., McCarthy, V.C., Miller, R.M. & Hornick, R.B. 1973. Specificity of protection of man immunized against sporozoite-induced falciparum malaria. Am. J. Med. Sci. 226: 398–403.
Cochrane, A.H., Aikawa, M., Jeng, M. & Nussenzweig, R.S. 1976. Antibody-induced ultrastructural changes of malarial sporozoites. J. Immunol. 116: 859–867.
Desowitz, R.S. 1975. Plasmodium berghei: immunogenic enhancement of antigen by adjuvant addition. Exp. Parasitol. 38: 6–13.
Desowitz, R.S., Miller, L.H., Buchanan, R.D. & Permpanich, B. 1969. The sites of deep vascular schizogony in Plasmodium coatneyi malaria. Trans. R. Soc. Trop. Med. Hyg. 63: 198–202.
Dvorak, J.A., Miller, L.H., Whitehouse, W.C. & Shiroishi, T. 1975. Invasion of erythrocytes by malaria merozoites. Science 187: 748–750.
Freund, J., Thomson, K.J., Sommer, H.E., Walter, A.W. & Pisani, T.M. 1948. Immunization of monkeys against malaria by means of killed parasites with adjuvants. Am. J. Trop. Med. Hyg. 28: 1–22.
James, S.P., Nicol, W.D. & Shute, P.G. 1932. A study of induced malignant tertian malaria. Proc. R. Soc. Med. 25: 1153–1186.
McGregor, I.A., Carrington, S.P. & Cohen, S. 1963. Treatment of East African P. falciparum with West African γ-globulin. Trans. R. Soc. Trop. Med. Hyg. 57: 170–175.
Miller, L.H., Aikawa, M. & Dvorak, J.A. 1975a. Malaria (Plasmodium knowlesi) merozoites: immunity and the surface coat. J. Immunol. 114: 1237–1242.
Miller, L.H., Mason, S.J., Clyde, D.F. & McGinniss, M.H. 1976a. Resistance factor to Plasmodium vivax: Duffy genotype FyFy. N. Engl. J. Med. 295: 302–304.
Miller, L.H., Mason, S.J., Dvorak, J.A., McGinniss, M.H. & Rothman, I.K. 1975b. Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants. Science 189: 561–563.
Miller, L.H., Powers, K.G. & Shiroishi, T. 1976b. Plasmodium knowlesi: Functional immunity and antimerozoite antibodies in Rhesus monkeys after repeated infection. Exp. Parasitol. In press.
Mitchell, G.H., Butcher, G.A. & Cohen, S. 1974. A merozoite vaccine effective against Plasmodium knowlesi malaria. Nature (Lond.) 252: 311–313.
Mitchell, G.H., Butcher, G.A. & Cohen, S. 1975. Merozoite vaccination against Plasmodium knowlesi malaria. Immunology 29: 397–407.
Schenkel, R.H., Cabrera, E.J., Barr, MX. & Silverman, P.H. 1975. A new adjuvant for use in vaccination against malaria. J. Parasitol. 63: 549–550.
Schenkel, R.H., Simpson, G.L. & Silverman, P.H. 1973. Vaccination of Rhesus monkeys (Maccaca mulatto) against Plasmodium knowlesi by the use of nonviable antigen. Bull WHO 48: 597–604.
Simpson, G.L., Schenkel, R.H. & Silverman, P.H. 1974. Vaccination of Rhesus monkeys against malaria by use of sucrose density gradient fractions of Plasmodium knowlesi antigens. Nature (Lond.) 247: 304–305.
Targett, G.A. & Fulton, J.D. 1965. Immunization of Rhesus monkeys against Plasmodium knowlesi malaria. Exp. Parasitol. 17: 180–193.
Trager, W. & Jensen, J.B. 1976. Human malaria parasites in continuous culture. Science 193: 673–674.
Voller, A. & Rossan, R.N. 1969. Immunological studies on simian malaria. 3. Immunity to challenge and antigenic variation in P. knowlesi. Trans. R. Soc. Trop. Med. Hyg. 63: 507–523.
Young, M.D., Eyles, D.E., Burgess, R.W. & Jeffery, G.M. 1955. Experimental testing of Negroes to Plasmodium vivax. J. Parasitol. 41: 315–318.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Plenum Press, New York
About this chapter
Cite this chapter
Miller, L.H. (1977). A Critique of Merozoite and Sporozoite Vaccines in Malaria. In: Miller, L.H., Pino, J.A., McKelvey, J.J. (eds) Immunity to Blood Parasites of Animals and Man. Advances in Experimental Medicine and Biology, vol 93. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-8855-9_8
Download citation
DOI: https://doi.org/10.1007/978-1-4615-8855-9_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-8857-3
Online ISBN: 978-1-4615-8855-9
eBook Packages: Springer Book Archive